KRON stock forecast
Our latest prediction for Kronos Bio Inc's stock price was made on the Nov. 22, 2023 when the stock price was at 1.24$.
In the short term (2weeks), KRON's stock price should underperform the market by -2.88%. During that period the price should oscillate between -12.10% and +5.49%.
In the medium term (3months), KRON's stock price should outperform the market by 6.83%. During that period the price should oscillate between -27.46% and +19.09%.Get email alerts
Create a solid portfolio with KRON
About Kronos Bio Inc
kronos bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. leveraging industry-leading research into high-throughput screening strategies for chemical modulators of transcription factors and other challenging targets in oncology, kronos utilizes its small molecule microarray (smm) platform and extensive know-how in biological assay development to pursue novel therapies against some of the most important and intractable targets in cancer research.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.08$ per share.
The book value per share is 1.54$
Three months stock forecastNov. 22, 2023
|Earnings Per Share
|Book Value Per Share
|Operating Cash Flow
|Free Cash Flow